---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009549"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:31:21.185381+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Naya Biosciences postpones 2024 annual meeting to April 9, 2025; all prior votes void

## Summary
- Annual meeting postponed from March 10 to April 9, 2025; new record date set for March 10, 2025.
- Standard proposals (director election, auditor ratification) have sufficient votes; special proposals (share issuance, plan amendment, authorized shares) lack required votes.
- All votes cast under the February proxy are null and void; new proxy card will be issued.
- Nasdaq granted extension until June 30, 2025 to regain compliance with annual meeting rule.

## SEC filing metadata
- accession: 0001493152-25-009549
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315225009549/0001493152-25-009549-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315225009549/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009549
- JSON: https://secwatch.observer/filing/0001493152-25-009549.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009549.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.